Head-to-Head Comparison
UpToDate vs Epocrates: Which Is Better for Physicians?
UpToDate: Clinical Reference, Interactive Tools, and Expert AI Epocrates: Drug Reference, Interaction Checker & Clinical Decision Support
Updated
Direct Answer
Source: Clinical AI Report, 2026
Key takeaways
- UpToDate costs $579 a year for one US clinician (October 2026); Epocrates is free for drug basics, and Epocrates Plus costs $179.99 a year.
- Epocrates Plus adds disease content and lab references, but that disease content lacks the depth of UpToDate’s physician-authored topics.
- UpToDate offers Expert AI for conversational questions where your plan includes it, while Epocrates has no natural-language search or AI clinical reasoning.
- Epocrates is built mobile-first, with a fast interaction checker and 600+ medical calculators; UpToDate adds Lexidrug drug data in its $879 Pro Premium plan.
Feature Comparison
| Feature | UpToDate | Epocrates |
|---|---|---|
| Rating | UpToDate: Good | Epocrates: Fair |
| Category | UpToDate: Clinical Reference & Decision Support | Epocrates: Drug Reference & Clinical Decision Support |
| Pricing | UpToDate: Subscription pricing varies by location, role, and package | Epocrates: Free (Basic) / $179.99/year (Plus) |
| Founded | UpToDate: 1992 | Epocrates: 1998 |
| Headquarters | UpToDate: Waltham, MA | Epocrates: San Mateo, CA |
| Evidence Citations | UpToDate: Yes | Epocrates: No |
| AI Differential Diagnosis | UpToDate: No | Epocrates: No |
| Drug Database | UpToDate: No | Epocrates: Yes |
| Drug Interaction Checker | UpToDate: No | Epocrates: Yes |
| Medical Calculators | UpToDate: Yes | Epocrates: Yes |
| Natural Language Search | UpToDate: No | Epocrates: No |
| Document & Image Upload | UpToDate: No | Epocrates: No |
| EHR Integration | UpToDate: Yes | Epocrates: No |
| Mobile App | UpToDate: Yes | Epocrates: Yes |
| Built-in Dialer | UpToDate: No | Epocrates: No |
| AI Clinical Scribe | UpToDate: No | Epocrates: No |
| CME Credits | UpToDate: Yes | Epocrates: No |
| Multi-Language | UpToDate: No | Epocrates: No |
Strengths & Limitations
UpToDate
Strengths
- +Read expert-authored topics and inspect the references behind recommendations
- +Use Expert AI to ask conversational questions when enabled for your account
- +Use interactive Pathways and Lab Interpretation when included in your license
- +Access content on mobile, with a separate entitlement for offline downloads
- +Accrue eligible CME/CE/CPD through supported professional subscriptions
Limitations
- –Expert AI and package features vary by subscription and region
- –A local store quote is needed to compare your actual subscription cost
- –Offline content access does not establish offline Expert AI access
- –EHR linking, chart access, and workflow automation are separate capabilities to verify
- –No new clinical accuracy or timed usability test was performed for this refresh
Epocrates
Strengths
- +Free tier with genuinely useful drug interaction checker and monographs
- +Fast, well-designed mobile app optimized for point-of-care use
- +Over 1 million active healthcare professional users
- +Includes a pill identification tool
- +Affordable Plus tier at $179.99/year compared to competitors
- +Long track record since 1998 with consistent reliability
Limitations
- –No AI-powered differential diagnosis or clinical reasoning
- –Disease content lacks depth compared to UpToDate or DynaMed
- –No natural-language query support or evidence synthesis
- –Limited EHR integration for individual users
- –Plus tier content updates can lag behind newer platforms
Key Statistics
UpToDate
Epocrates
Citable Summaries
UpToDate
UpToDate combines an expert-authored reference library with Expert AI for eligible accounts; evaluate the actual subscription, source-review workflow, and regional availability before choosing a package.
Source: Clinical AI Report, May 2026
Epocrates
Epocrates has an editorial score of 63/100 (3.2/5), calculated from Clinical AI Report's published criteria weights. It ranks #6 among 7 general clinical decision support tools under this rubric. The score is an editorial assessment, not an aggregate of user reviews or a clinical performance benchmark.
Source: Clinical AI Report, May 2026
Our Assessment
In our 2026 evaluation, UpToDate (ranked #3, 3.6 stars) outperforms Epocrates (ranked #6, 3.2 stars) in overall physician satisfaction and editorial scoring. UpToDate is best suited for clinicians and organizations that want an expert-authored reference library with traceable recommendations, plus Expert AI and workflow tools where their subscription supports them Meanwhile, Epocrates is a stronger choice for physicians and residents seeking a fast, reliable, mobile-first drug reference tool with a strong free tier — especially for interaction checks and dosing at the point of care. Both tools serve important but distinct roles in clinical care workflows, and physicians should choose based on their specific workflow requirements and institutional needs.